Dates: April 18-22, 2026
Location: McCormick Place, Chicago, Illinois, USA
Organizer: American Academy of Neurology
Website: aanannualmeeting.com
AAN 2026 will be held in Los Angeles, continuing the tradition of the world's largest neurology conference. The meeting will feature the latest advances in neurological research and clinical practice, bringing together over 12,000 neurologists, neuroscientists, and neurology trainees from around the world.
The American Academy of Neurology's Annual Meeting is the premier event for the neurology community, showcasing groundbreaking research across all subspecialties of neurology. AAN 2026 will emphasize precision medicine, biomarkers, and novel therapeutic approaches for neurological disorders.
- November 2025: Abstract submission opens
- February 2026: Early registration deadline
- April 18-22, 2026: Main conference
- April 16, 2026: Post-conference workshops
- Over 12,000 in-person attendees
- More than 3,000 scientific abstracts
- Over 200 educational sessions
- Representatives from 100+ countries
- Plenary Sessions: Keynote addresses from leading researchers
- Scientific Sessions: Platform presentations of original research
- Poster Sessions: Visual presentations of ongoing research
- Workshops: Hands-on clinical skill building
- Courses: Didactic teaching sessions
- Late-Breaking Science: Results from recently completed trials
The neurodegeneration track will feature significant advances in Alzheimer's disease, Parkinson's disease, and other progressive neurological conditions:
- Blood-based biomarkers: Clinical implementation of p-tau217, p-tau181, andNfL
- Anti-amyloid therapies: Updates on lecanemab, donanemab, and next-generation antibodies
- Anti-tau therapies: Results from Phase 2 and 3 trials
- Precision medicine: Genetic and biomarker-guided treatment approaches
- Prevention trials: Updates from the A4, DIAN, and API trials
¶ Parkinson's Disease and Movement Disorders
- Alpha-synuclein targeting: Immunotherapies and small molecules
- DBS advances: Directional leads and closed-loop systems
- Gene therapy: Results from ongoing trials
- Neuroprotection: Disease-modifying strategies
- Non-motor symptoms: Sleep, autonomic dysfunction, and cognition
- Stroke prevention: Anticoagulation and antiplatelet strategies
- Acute stroke treatment: Thrombolysis and thrombectomy updates
- Vascular cognitive impairment: Mechanisms and prevention
- Small vessel disease: MRI biomarkers and treatment targets
- Novel antiseizure medications
- Surgical treatment advances
- SUDEP risk reduction
- Genetics and precision medicine
- Device-based therapies (RNS, VNS)
- B-cell and T-cell therapies
- Progressive MS treatments
- Remyelination strategies
- Biomarkers of treatment response
- Genetic therapies for SMA and Duchenne
- Amyotrophic lateral sclerosis trials
- Myasthenia gravis biologics
- Peripheral neuropathy treatments
¶ 6. Headache and Pain
- CGRP and related targeted therapies
- Neuromodulation devices
- Chronic migraine prevention
- Post-herpetic neuralgia
¶ Education and Professional Development
- Early Career Neurology Session
- Mentorship programs
- Research funding workshops
- Practice management courses
- Hands-on workshops
- Simulation training
- Case-based learning
- Board review courses
Located in downtown Los Angeles, the LACC offers:
- State-of-the-art presentation facilities
- Multiple exhibit halls
- Proximity to hotels and restaurants
- Easy access from LAX airport
Los Angeles is home to:
- University of California Los Angeles (UCLA) Neurology
- University of Southern California (USC) Neurology
- Cedars-Sinai Medical Center
- Multiple VA healthcare facilities
- Thriving biotech and pharmaceutical industry
While specific programs are released closer to the conference, AAN 2026 is expected to feature:
- President's Lecture on the future of neurology
- Distinguished Teacher Award Lecture
- A.B. Baker Award for Neurology Education
- Clinical trial results in Alzheimer's disease
- Parkinson's disease treatment advances
- Stroke prevention studies
- Novel therapeutic approaches
- Diversity and inclusion in neurology
- Global neurology initiatives
- Climate and neurological health
- AI in neurological practice
¶ Registration and Travel
- Member (MD/PhD)
- Non-member
- Resident/Fellow
- Medical Student
- Allied Health Professional
- Virtual access
- Major airports: LAX, Burbank, Long Beach
- Hotel discounts available
- Visa assistance for international attendees
- AAIC 2026 — Alzheimer's Association International Conference](/events)
- MDS 2026 — Movement Disorder Society](/events)
- AD/PD 2026 — Alzheimer's Disease/Parkinson's Disease](/events)
- CTAD 2026 — Clinical Trials on Alzheimer's Disease